Howe & Rusling’s Regeneron Pharmaceuticals REGN Stock Holding History

Howe & Rusling’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$326K	Buy	621 +60	+11%	+$31.5K	0.02%	220
2025 Q1	$356K	Buy	561 +55	+11%	+$34.9K	0.03%	193
2024 Q4	$360K	Buy	506 +44	+10%	+$31.3K	0.03%	194
2024 Q3	$486K	Buy	462 +15	+3%	+$15.8K	0.04%	161
2024 Q2	$470K	Buy	447 +36	+9%	+$37.8K	0.04%	156
2024 Q1	$396K	Sell	411 -43	-9%	-$41.4K	0.04%	178
2023 Q4	$399K	Buy	454 +9	+2%	+$7.91K	0.04%	153
2023 Q3	$366K	Buy	445 +7	+2%	+$5.76K	0.04%	152
2023 Q2	$315K	Hold	438	–	–	0.04%	175
2023 Q1	$360K	Hold	438	–	–	0.04%	161
2022 Q4	$316K	Hold	438	–	–	0.04%	160
2022 Q3	$302K	Hold	438	–	–	0.04%	160
2022 Q2	$259K	Hold	438	–	–	0.03%	173
2022 Q1	$306K	Hold	438	–	–	0.04%	163
2021 Q4	$277K	Sell	438 -1	-0.2%	-$632	0.03%	176
2021 Q3	$266K	Buy	439 +1	+0.2%	+$606	0.03%	170
2021 Q2	$245K	Hold	438	–	–	0.03%	165
2021 Q1	$207K	Buy	438 +175	+67%	+$82.7K	0.03%	173
2020 Q4	$127K	Hold	263	–	–	0.02%	202
2020 Q3	$147K	Buy	263 +18	+7%	+$10.1K	0.03%	176
2020 Q2	$153K	Hold	245	–	–	0.03%	160
2020 Q1	$120K	Hold	245	–	–	0.03%	179
2019 Q4	$92K	Buy	+245	New	+$92K	0.02%	239
2018 Q4	–	Sell	-25	Closed	-$10K	–	884
2018 Q3	$10K	Buy	+25	New	+$10K	﹤0.01%	507
2018 Q2	–	Sell	-40	Closed	-$14K	–	915
2018 Q1	$14K	Buy	40 +35	+700%	+$12.3K	﹤0.01%	440
2017 Q4	$2K	Hold	5	–	–	﹤0.01%	728
2017 Q3	$2K	Sell	5 -20	-80%	-$8K	﹤0.01%	771
2017 Q2	$12K	Buy	25 +20	+400%	+$9.6K	﹤0.01%	449
2017 Q1	$2K	Hold	5	–	–	﹤0.01%	860
2016 Q4	$2K	Hold	5	–	–	﹤0.01%	884
2016 Q3	$2K	Hold	5	–	–	﹤0.01%	880
2016 Q2	$2K	Hold	5	–	–	﹤0.01%	839
2016 Q1	$2K	Hold	5	–	–	﹤0.01%	872
2015 Q4	$3K	Hold	5	–	–	﹤0.01%	748
2015 Q3	$2K	Hold	5	–	–	﹤0.01%	842
2015 Q2	$3K	Buy	+5	New	+$3K	﹤0.01%	790
2014 Q2	–	Sell	-111	Closed	-$33K	–	913
2014 Q1	$33K	Buy	+111	New	+$33K	0.01%	381
2013 Q4	–	Sell	-147	Closed	-$45K	–	871
2013 Q3	$45K	Hold	147	–	–	0.02%	342
2013 Q2	$33K	Buy	+147	New	+$33K	0.01%	407